Literature DB >> 23851068

Resting-state fMRI connectivity impairment in schizophrenia and bipolar disorder.

Miklos Argyelan1, Toshikazu Ikuta, Pamela DeRosse, Raphael J Braga, Katherine E Burdick, Majnu John, Peter B Kingsley, Anil K Malhotra, Philip R Szeszko.   

Abstract

BACKGROUND: Schizophrenia and bipolar disorder share aspects of phenomenology and neurobiology and thus may represent a continuum of disease. Few studies have compared connectivity across the brain in these disorders or investigated their functional correlates.
METHODS: We used resting-state functional magnetic resonance imaging to evaluate global and regional connectivity in 32 healthy controls, 19 patients with bipolar disorder, and 18 schizophrenia patients. Patients also received comprehensive neuropsychological and clinical assessments. We computed correlation matrices among 266 regions of interest within the brain, with the primary dependent measure being overall global connectivity strength of each region with every other region.
RESULTS: Patients with schizophrenia had significantly lower global connectivity compared with healthy controls, whereas patients with bipolar disorder had global connectivity intermediate to and significantly different from those of patients with schizophrenia and healthy controls. Post hoc analyses revealed that compared with healthy controls, both patient groups had significantly lower connectivity in the paracingulate gyrus and right thalamus. Patients with schizophrenia also had significantly lower connectivity in the temporal occipital fusiform cortex, left caudate nucleus, and left thalamus compared with healthy controls. There were no significant differences among the patient groups in any of these regions. Lower global connectivity among all patients was associated with worse neuropsychological and clinical functioning, but these effects were not specific to any patient group.
CONCLUSIONS: These findings are consistent with the hypothesis that schizophrenia and bipolar disorder may represent a continuum of global disconnectivity in the brain but that regional functional specificity may not be evident.

Entities:  

Keywords:  bipolar disorder; connectivity; resting-state fMRI; schizophrenia

Mesh:

Year:  2013        PMID: 23851068      PMCID: PMC3885301          DOI: 10.1093/schbul/sbt092

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  60 in total

1.  First psychiatric hospitalizations in the US military: the National Collaborative Study of Early Psychosis and Suicide (NCSEPS).

Authors:  Richard Herrell; Ioline D Henter; Ramin Mojtabai; John J Bartko; Diane Venable; Ezra Susser; Kathleen R Merikangas; Richard J Wyatt
Journal:  Psychol Med       Date:  2006-07-31       Impact factor: 7.723

2.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder.

Authors:  Michael F Green
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

Review 3.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

Review 4.  G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis.

Authors:  Sevilla D Detera-Wadleigh; Francis J McMahon
Journal:  Biol Psychiatry       Date:  2006-04-11       Impact factor: 13.382

Review 5.  What do we know about neuropsychological aspects of schizophrenia?

Authors:  Barton W Palmer; Sharron E Dawes; Robert K Heaton
Journal:  Neuropsychol Rev       Date:  2009-07-30       Impact factor: 7.444

Review 6.  Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence.

Authors:  Lucy J Robinson; I Nicol Ferrier
Journal:  Bipolar Disord       Date:  2006-04       Impact factor: 6.744

7.  The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.

Authors:  Robert S Kern; Keith H Nuechterlein; Michael F Green; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Jim Mintz; Larry J Seidman; Ellen Stover; Stephen R Marder
Journal:  Am J Psychiatry       Date:  2008-01-02       Impact factor: 18.112

8.  Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia.

Authors:  Lyudmila Georgieva; Albena Dimitrova; Dobril Ivanov; Ivan Nikolov; Nigel M Williams; Detelina Grozeva; Irina Zaharieva; Draga Toncheva; Michael J Owen; George Kirov; Michael C O'Donovan
Journal:  Biol Psychiatry       Date:  2008-05-07       Impact factor: 13.382

9.  Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Authors:  Joseph I Friedman; Cheuk Tang; David Carpenter; Monte Buchsbaum; James Schmeidler; Lauren Flanagan; Shana Golembo; Isabella Kanellopoulou; Johnny Ng; Patrick R Hof; Philip D Harvey; Nicholas D Tsopelas; Daniel Stewart; Kenneth L Davis
Journal:  Am J Psychiatry       Date:  2008-06-16       Impact factor: 18.112

10.  Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder.

Authors:  Jennifer S Perrin; Susanne Merz; Daniel M Bennett; James Currie; Douglas J Steele; Ian C Reid; Christian Schwarzbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

View more
  56 in total

1.  Generation and Evaluation of a Cortical Area Parcellation from Resting-State Correlations.

Authors:  Evan M Gordon; Timothy O Laumann; Babatunde Adeyemo; Jeremy F Huckins; William M Kelley; Steven E Petersen
Journal:  Cereb Cortex       Date:  2014-10-14       Impact factor: 5.357

Review 2.  Resting state fMRI: A review on methods in resting state connectivity analysis and resting state networks.

Authors:  K A Smitha; K Akhil Raja; K M Arun; P G Rajesh; Bejoy Thomas; T R Kapilamoorthy; Chandrasekharan Kesavadas
Journal:  Neuroradiol J       Date:  2017-03-29

3.  Abnormal resting state FMRI activity predicts processing speed deficits in first-episode psychosis.

Authors:  Miklos Argyelan; Juan A Gallego; Delbert G Robinson; Toshikazu Ikuta; Deepak Sarpal; Majnu John; Peter B Kingsley; John Kane; Anil K Malhotra; Philip R Szeszko
Journal:  Neuropsychopharmacology       Date:  2015-01-08       Impact factor: 7.853

4.  Cerebellar-thalamic connectivity in schizophrenia.

Authors:  Deanna M Barch
Journal:  Schizophr Bull       Date:  2014-06-03       Impact factor: 9.306

5.  Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic Schizophrenia.

Authors:  Qi Miao; Chengcheng Pu; Zhijiang Wang; Chao-Gan Yan; Chuan Shi; Qingjiu Cao; Xijin Wang; Zhang Cheng; Xue Han; Lei Yang; Yunyao Lai; Yanbo Yuan; Hong Ma; Keqing Li; Nan Hong; Xin Yu
Journal:  Can J Psychiatry       Date:  2020-02-06       Impact factor: 4.356

6.  Aberrant intrinsic functional connectivity within and between corticostriatal and temporal-parietal networks in adults and youth with bipolar disorder.

Authors:  J Stoddard; S J Gotts; M A Brotman; S Lever; D Hsu; C Zarate; M Ernst; D S Pine; E Leibenluft
Journal:  Psychol Med       Date:  2016-02-29       Impact factor: 7.723

Review 7.  Mind-wandering as spontaneous thought: a dynamic framework.

Authors:  Kalina Christoff; Zachary C Irving; Kieran C R Fox; R Nathan Spreng; Jessica R Andrews-Hanna
Journal:  Nat Rev Neurosci       Date:  2016-09-22       Impact factor: 34.870

Review 8.  A systems neuroscience perspective of schizophrenia and bipolar disorder.

Authors:  Sophia Frangou
Journal:  Schizophr Bull       Date:  2014-03-08       Impact factor: 9.306

9.  Altered resting state functional connectivity in early course schizophrenia.

Authors:  Aastha Sharma; Arvind Kumar; Sadhana Singh; Triptish Bhatia; R P Beniwal; Subash Khushu; Konasale M Prasad; Smita N Deshpande
Journal:  Psychiatry Res Neuroimaging       Date:  2017-11-22       Impact factor: 2.376

Review 10.  Cellular and circuit models of increased resting-state network gamma activity in schizophrenia.

Authors:  R S White; S J Siegel
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.